Mark J. Gergen
2013 - Mirati Therapeutics
In 2013, Mark J. Gergen earned a total compensation of $1.4M as Executive Vice President and Chief Operations Officer at Mirati Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $155,000 |
|---|---|
| Option Awards | $979,945 |
| Salary | $311,539 |
| Other | $3,120 |
| Total | $1,449,604 |
Gergen received $979.9K in option awards, accounting for 68% of the total pay in 2013.
Gergen also received $155K in non-equity incentive plan, $311.5K in salary and $3.1K in other compensation.
Rankings
In 2013, Mark J. Gergen's compensation ranked 5,086th out of 12,286 executives tracked by ExecPay. In other words, Gergen earned more than 58.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,086 out of 12,286 | 59th |
Division Manufacturing | 1,756 out of 4,612 | 62nd |
Major group Chemicals And Allied Products | 507 out of 1,466 | 65th |
Industry group Drugs | 361 out of 1,160 | 69th |
Industry Pharmaceutical Preparations | 288 out of 890 | 68th |
Source: SEC filing on April 23, 2015.
Gergen's colleagues
We found two more compensation records of executives who worked with Mark J. Gergen at Mirati Therapeutics in 2013.